From Breakthrough to Impact: Launching the NeuroLife® Company

In today’s pharma and biotech industries, choosing the right R&D partner is a strategic decision that can shape the trajectory of your entire program. Beyond credentials and case studies, the real differentiator lies in how a partner thinks, collaborates, and evolves. Here's four key questions every leader should ask before hiring a R&D partner.

Special Forces operate at peak intensity for decades—but that performance comes with a cumulative physical and psychological cost. Explore how chronic pain, injury, and allostatic load impact long-term readiness, and why early, integrated, whole-system interventions are essential to sustaining performance, extending careers and improving post-service quality of life.

Poor and interrupted sleep is simply a reality of SOF life.That’s why sleep is increasingly recognized within SOF not as a wellness issue, but as a readiness variable that the force must treat. The question is how we apply what the research already tells us, at scale, across the force.

New Approach Methodologies (NAMs) are poised to transform preclinical research and toxicology. Right now there are three interconnected barriers to in vitro NAMs adoption. Moving NAMs into the mainstream will require approaches that tackle all three together.

New Approach Methodologies (NAMs) have demonstrated tremendous promise but there are still structural barriers standing in the way of widespread NAMs adoption. Here how to understand those gaps in promise vs. practice.